LivaNova (LIVN) Selling, General & Administrative (2014 - 2026)
LivaNova (LIVN) Selling, General & Administrative (2014 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | SG&A (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.77 Bn | 194.17 Bn | 7.27 Bn | 4.03 Bn |
| 2 | Stryker | 129.56 Bn | 126.08 Bn | 4.50 Bn | 2.23 Bn |
| 3 | Medtronic | 120.09 Bn | 110.87 Bn | 6.41 Bn | 3.06 Bn |
| 4 | Boston Scientific | 73.80 Bn | 73.26 Bn | 3.85 Bn | 1.80 Bn |
| 5 | Edwards Lifesciences | 52.68 Bn | 48.43 Bn | 1.35 Bn | 561.20 Mn |
| 6 | Dexcom | 34.60 Bn | 32.65 Bn | 830.00 Mn | 358.70 Mn |
| 7 | GE HealthCare Technologies | 34.10 Bn | 31.99 Bn | 2.18 Bn | 1.12 Bn |
| 8 | Koninklijke Philips | 26.45 Bn | 23.12 Bn | 4.55 Bn | -179.00 Mn |
| 9 | Steris | 23.20 Bn | 22.72 Bn | 684.20 Mn | 369.70 Mn |
| 10 | LivaNova | 4.35 Bn | 3.83 Bn | 273.67 Mn | 158.13 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 158.13 Mn |
| Mar 31, 2026 | 143.57 Mn |
| Dec 31, 2025 | 143.37 Mn |
| Sep 30, 2025 | 138.52 Mn |
| Jun 30, 2025 | 137.78 Mn |
| Mar 31, 2025 | 129.15 Mn |
| Dec 31, 2024 | 130.64 Mn |
| Sep 30, 2024 | 127.43 Mn |
| Jun 30, 2024 | 125.13 Mn |
| Mar 31, 2024 | 125.68 Mn |
| Dec 31, 2023 | 117.90 Mn |
| Sep 30, 2023 | 134.79 Mn |
| Jun 30, 2023 | 125.87 Mn |
| Mar 31, 2023 | 124.13 Mn |
| Dec 31, 2022 | 119.61 Mn |
| Sep 30, 2022 | 114.63 Mn |
| Jun 30, 2022 | 116.48 Mn |
| Mar 31, 2022 | 118.53 Mn |
| Dec 31, 2021 | 124.43 Mn |
| Sep 30, 2021 | 109.04 Mn |